Vespula pensylvanica isolate Volc-1 chromosome 17, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025352.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
alkaline phosphatase 4, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
alkaline phosphatase 4, transcript variant X3
alkaline phosphatase 4, transcript variant X2
tyramine receptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tyramine receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
tyramine receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
delta-1-pyrroline-5-carboxylate synthase, transcript variant X2
delta-1-pyrroline-5-carboxylate synthase, transcript variant X1
delta-1-pyrroline-5-carboxylate synthase
U4/U6 small nuclear ribonucleoprotein Prp4
cysteine-rich hydrophobic domain-containing protein 2
SH3 domain-containing protein 19-like, transcript variant X1
SH3 domain-containing protein 19-like, transcript variant X2
SH3 domain-containing protein 19-like isoform X1
SH3 domain-containing protein 19-like isoform X2
chromatin complexes subunit BAP18, transcript variant X2
chromatin complexes subunit BAP18 isoform X2
chromatin complexes subunit BAP18, transcript variant X1
chromatin complexes subunit BAP18 isoform X1
major facilitator superfamily domain-containing protein 1-like, transcript variant X2
major facilitator superfamily domain-containing protein 1-like, transcript variant X1
major facilitator superfamily domain-containing protein 1-like isoform X1
major facilitator superfamily domain-containing protein 1-like isoform X2
ATP-dependent RNA helicase DHX33, transcript variant X2
ATP-dependent RNA helicase DHX33, transcript variant X1
uncharacterized LOC122635165, transcript variant X5
uncharacterized LOC122635165, transcript variant X2
uncharacterized LOC122635165, transcript variant X3
uncharacterized LOC122635165, transcript variant X4
uncharacterized LOC122635165, transcript variant X6
uncharacterized LOC122635165, transcript variant X8
uncharacterized LOC122635165, transcript variant X7
uncharacterized LOC122635165, transcript variant X9
uncharacterized LOC122635165, transcript variant X1
TBC1 domain family member 25, transcript variant X1
TBC1 domain family member 25, transcript variant X2
growth hormone-inducible transmembrane protein-like, transcript variant X4
growth hormone-inducible transmembrane protein-like, transcript variant X1
growth hormone-inducible transmembrane protein-like, transcript variant X3
growth hormone-inducible transmembrane protein-like, transcript variant X5
growth hormone-inducible transmembrane protein-like, transcript variant X2
growth hormone-inducible transmembrane protein-like
transcription factor SPT20 homolog, transcript variant X2
transcription factor SPT20 homolog, transcript variant X1
transcription factor SPT20 homolog, transcript variant X5
transcription factor SPT20 homolog, transcript variant X3
transcription factor SPT20 homolog, transcript variant X4
ras guanine nucleotide exchange factor B isoform X1
transcription factor SPT20 homolog isoform X2
rho-associated protein kinase 2, transcript variant X5
rho-associated protein kinase 2, transcript variant X4
rho-associated protein kinase 2, transcript variant X3
rho-associated protein kinase 2, transcript variant X2
rho-associated protein kinase 2, transcript variant X1
rho-associated protein kinase 2 isoform X3
rho-associated protein kinase 2 isoform X2
rho-associated protein kinase 2 isoform X1
uncharacterized LOC122635254, transcript variant X1
uncharacterized LOC122635254, transcript variant X2
uncharacterized LOC122635254, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized protein LOC122635254 isoform X1
uncharacterized protein LOC122635254 isoform X2
ATPase WRNIP1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
ATPase WRNIP1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ATPase WRNIP1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ATPase WRNIP1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
methyltransferase-like 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
methyltransferase-like 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
methyltransferase-like 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
WD repeat-containing protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
WD repeat-containing protein 7, transcript variant X1
WD repeat-containing protein 7, transcript variant X4
WD repeat-containing protein 7, transcript variant X9
WD repeat-containing protein 7, transcript variant X10
WD repeat-containing protein 7, transcript variant X3
WD repeat-containing protein 7, transcript variant X6
WD repeat-containing protein 7, transcript variant X7
WD repeat-containing protein 7, transcript variant X5
WD repeat-containing protein 7, transcript variant X8
WD repeat-containing protein 7 isoform X1
WD repeat-containing protein 7 isoform X3
WD repeat-containing protein 7 isoform X8
WD repeat-containing protein 7 isoform X9
WD repeat-containing protein 7 isoform X2
WD repeat-containing protein 7 isoform X5
WD repeat-containing protein 7 isoform X6
WD repeat-containing protein 7 isoform X4
WD repeat-containing protein 7 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable nuclear hormone receptor HR3, transcript variant X3
probable nuclear hormone receptor HR3, transcript variant X4
probable nuclear hormone receptor HR3, transcript variant X2
probable nuclear hormone receptor HR3, transcript variant X1
probable nuclear hormone receptor HR3, transcript variant X5
probable nuclear hormone receptor HR3 isoform X2
probable nuclear hormone receptor HR3 isoform X3
probable nuclear hormone receptor HR3 isoform X1
probable nuclear hormone receptor HR3 isoform X4
histidine decarboxylase, transcript variant X3
histidine decarboxylase, transcript variant X1
histidine decarboxylase, transcript variant X2
uncharacterized protein DDB_G0283697-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 13-like, transcript variant X1
coiled-coil domain-containing protein 13-like, transcript variant X2
coiled-coil domain-containing protein 13-like isoform X1
coiled-coil domain-containing protein 13-like isoform X2
uncharacterized LOC122635204, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122635204, transcript variant X2
uncharacterized LOC122635204, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X2
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X1
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X3
phosphoinositide 3-kinase regulatory subunit 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phosphoinositide 3-kinase regulatory subunit 4 isoform X4
phosphoinositide 3-kinase regulatory subunit 4 isoform X1
phosphoinositide 3-kinase regulatory subunit 4 isoform X2
phosphoinositide 3-kinase regulatory subunit 4 isoform X3
vesicle transport protein SEC20, transcript variant X7
vesicle transport protein SEC20, transcript variant X6
vesicle transport protein SEC20, transcript variant X4
vesicle transport protein SEC20, transcript variant X5
vesicle transport protein SEC20, transcript variant X3
vesicle transport protein SEC20, transcript variant X2
vesicle transport protein SEC20, transcript variant X1
isocitrate dehydrogenase [NAD] subunit beta, mitochondrial
methenyltetrahydrofolate synthase domain-containing protein
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like isoform X2
facilitated trehalose transporter Tret1-2 homolog
26S proteasome non-ATPase regulatory subunit 2-like
26S proteasome regulatory subunit RPN1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X19
actin-binding LIM protein 2, transcript variant X7
actin-binding LIM protein 2, transcript variant X12
actin-binding LIM protein 2, transcript variant X11
actin-binding LIM protein 2, transcript variant X5
actin-binding LIM protein 2, transcript variant X2
actin-binding LIM protein 2, transcript variant X10
actin-binding LIM protein 2, transcript variant X4
actin-binding LIM protein 2, transcript variant X1
actin-binding LIM protein 2, transcript variant X9
actin-binding LIM protein 2, transcript variant X18
actin-binding LIM protein 2, transcript variant X3
actin-binding LIM protein 2, transcript variant X6
actin-binding LIM protein 2, transcript variant X8
actin-binding LIM protein 2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
actin-binding LIM protein 2, transcript variant X13
actin-binding LIM protein 2, transcript variant X17
actin-binding LIM protein 2, transcript variant X16
actin-binding LIM protein 2, transcript variant X15
LIM domain only protein 3-like, transcript variant X3
LIM domain only protein 3-like, transcript variant X4
LIM domain only protein 3-like, transcript variant X1
LIM domain only protein 3-like, transcript variant X2
uncharacterized protein LOC122635208 isoform X4
LIM domain only protein 3-like isoform X1
LIM domain only protein 3-like isoform X2
LIM domain only protein 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase UBR2, transcript variant X1
E3 ubiquitin-protein ligase UBR2, transcript variant X2
transcription initiation factor TFIID subunit 3
CCR4-NOT transcription complex subunit 11
dynein heavy chain, cytoplasmic, transcript variant X2
dynein heavy chain, cytoplasmic, transcript variant X1
dynein heavy chain, cytoplasmic, transcript variant X3
dynein heavy chain, cytoplasmic, transcript variant X4
dynein heavy chain, cytoplasmic, transcript variant X5
dynein heavy chain, cytoplasmic isoform X2
dynein heavy chain, cytoplasmic isoform X1
dynein heavy chain, cytoplasmic isoform X3
dynein heavy chain, cytoplasmic isoform X4
dynein heavy chain, cytoplasmic isoform X5
sodium-dependent transporter bedraggled, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
sodium-dependent transporter bedraggled, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium-dependent transporter bedraggled, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent transporter bedraggled, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium-dependent transporter bedraggled isoform X2
sodium-dependent transporter bedraggled isoform X1
sodium-dependent transporter bedraggled isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
acetyl-CoA acetyltransferase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
acetyl-CoA acetyltransferase, mitochondrial isoform X1
acetyl-CoA acetyltransferase, mitochondrial, transcript variant X2
acetyl-CoA acetyltransferase, mitochondrial isoform X2
acetyl-CoA acetyltransferase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
acetyl-CoA acetyltransferase, mitochondrial isoform X3
death-associated inhibitor of apoptosis 2, transcript variant X1
death-associated inhibitor of apoptosis 2, transcript variant X2
death-associated inhibitor of apoptosis 2 isoform X1
death-associated inhibitor of apoptosis 2 isoform X2
dual specificity protein phosphatase CDC14A-like, transcript variant X4
dual specificity protein phosphatase CDC14A-like isoform X4
dual specificity protein phosphatase CDC14A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dual specificity protein phosphatase CDC14C-like isoform X3
dual specificity protein phosphatase CDC14A-like, transcript variant X6
dual specificity protein phosphatase CDC14A-like, transcript variant X7
dual specificity protein phosphatase CDC14A-like isoform X6
dual specificity protein phosphatase CDC14A-like, transcript variant X8
dual specificity protein phosphatase CDC14A-like, transcript variant X5
dual specificity protein phosphatase CDC14A-like, transcript variant X1
dual specificity protein phosphatase CDC14A-like, transcript variant X2
dual specificity protein phosphatase CDC14C-like isoform X1
dual specificity protein phosphatase CDC14A-like isoform X7
dual specificity protein phosphatase CDC14C-like isoform X2
dual specificity protein phosphatase CDC14A-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
F-box only protein 44-like, transcript variant X2
F-box only protein 44-like, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 41 member 3, transcript variant X1
solute carrier family 41 member 3, transcript variant X2
solute carrier family 41 member 3 isoform X1
solute carrier family 41 member 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 4-like, transcript variant X2
FYVE, RhoGEF and PH domain-containing protein 4-like, transcript variant X1
FYVE, RhoGEF and PH domain-containing protein 4-like, transcript variant X3
FYVE, RhoGEF and PH domain-containing protein 4-like
RNA exonuclease 1 homolog, transcript variant X1
RNA exonuclease 1 homolog, transcript variant X2
solute carrier family 41 member 1-like, transcript variant X3
solute carrier family 41 member 1-like, transcript variant X4
solute carrier family 41 member 1-like, transcript variant X5
solute carrier family 41 member 1-like, transcript variant X2
solute carrier family 41 member 1-like, transcript variant X1
solute carrier family 41 member 1-like isoform X3
solute carrier family 41 member 1-like isoform X2
solute carrier family 41 member 1-like isoform X1
solute carrier family 41 member 1-like isoform X4
facilitated trehalose transporter Tret1-like, transcript variant X4
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like isoform X3
facilitated trehalose transporter Tret1-like, transcript variant X5
facilitated trehalose transporter Tret1-like, transcript variant X6
facilitated trehalose transporter Tret1-like isoform X4
phenoloxidase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 148 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
phenoloxidase 1-like, transcript variant X1
nuclear pore complex protein Nup58-like, transcript variant X1
nuclear pore complex protein Nup58-like, transcript variant X2
nuclear pore complex protein Nup58-like, transcript variant X7
nuclear pore complex protein Nup58-like, transcript variant X8
nuclear pore complex protein Nup58-like, transcript variant X5
nuclear pore complex protein Nup58-like, transcript variant X6
nuclear pore complex protein Nup58-like, transcript variant X3
nuclear pore complex protein Nup58-like, transcript variant X4
nuclear pore complex protein Nup58-like isoform X4
RNA-binding protein 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine/threonine-protein kinase VRK1-like, transcript variant X2
serine/threonine-protein kinase VRK1-like, transcript variant X1
serine/threonine-protein kinase VRK1-like, transcript variant X3
serine/threonine-protein kinase VRK1-like, transcript variant X4
serine/threonine-protein kinase VRK1-like isoform X2
serine/threonine-protein kinase VRK1-like isoform X1
serine/threonine-protein kinase VRK1-like isoform X3
RNA-binding protein 25, transcript variant X3
RNA-binding protein 25, transcript variant X1
RNA-binding protein 25, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
uncharacterized LOC122635127, transcript variant X2
uncharacterized LOC122635127, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122635125, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122635125, transcript variant X2
uncharacterized LOC122635125, transcript variant X3
C2 domain-containing protein 3-like, transcript variant X1
C2 domain-containing protein 3-like, transcript variant X3
C2 domain-containing protein 3-like, transcript variant X2
C2 domain-containing protein 3-like isoform X1
uncharacterized protein LOC122635032 isoform X2
C2 domain-containing protein 3-like, transcript variant X4
uncharacterized protein LOC122635032 isoform X3
general transcription factor IIH subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
general transcription factor IIH subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
general transcription factor IIH subunit 1 isoform X1
general transcription factor IIH subunit 1 isoform X2
uncharacterized LOC122635210, transcript variant X1
uncharacterized LOC122635210, transcript variant X2
uncharacterized protein LOC122635210 isoform X1
uncharacterized protein LOC122635210 isoform X2
POC1 centriolar protein homolog A-like, transcript variant X4
POC1 centriolar protein homolog A-like, transcript variant X3
POC1 centriolar protein homolog A-like, transcript variant X1
POC1 centriolar protein homolog A-like, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
putative tricarboxylate transport protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
peptidyl-tRNA hydrolase 2, mitochondrial-like, transcript variant X2
peptidyl-tRNA hydrolase 2, mitochondrial-like, transcript variant X1
peptidyl-tRNA hydrolase 2, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
gamma-interferon-inducible lysosomal thiol reductase-like, transcript variant X3
gamma-interferon-inducible lysosomal thiol reductase-like, transcript variant X4
gamma-interferon-inducible lysosomal thiol reductase-like, transcript variant X1
gamma-interferon-inducible lysosomal thiol reductase-like, transcript variant X2
gamma-interferon-inducible lysosomal thiol reductase-like, transcript variant X5
gamma-interferon-inducible lysosomal thiol reductase-like isoform X2
gamma-interferon-inducible lysosomal thiol reductase-like isoform X1
DNA-directed RNA polymerases I and III subunit RPAC1
guanine nucleotide-binding protein subunit gamma-1
RNA polymerase-associated protein RTF1 homolog
cofilin/actin-depolymerizing factor homolog, transcript variant X2
cofilin/actin-depolymerizing factor homolog isoform X2
cofilin/actin-depolymerizing factor homolog, transcript variant X1
cofilin/actin-depolymerizing factor homolog isoform X1
limbic system-associated membrane protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122635147, transcript variant X2
uncharacterized LOC122635147, transcript variant X4
uncharacterized protein LOC122635147 isoform X2
uncharacterized LOC122635147, transcript variant X3
uncharacterized LOC122635147, transcript variant X1
uncharacterized protein LOC122635147 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
signal recognition particle 9 kDa protein
band 4.1-like protein 4, transcript variant X6
band 4.1-like protein 4, transcript variant X7
band 4.1-like protein 4, transcript variant X3
band 4.1-like protein 4, transcript variant X4
band 4.1-like protein 4, transcript variant X5
band 4.1-like protein 4, transcript variant X11
band 4.1-like protein 4, transcript variant X9
band 4.1-like protein 4, transcript variant X2
band 4.1-like protein 4, transcript variant X1
band 4.1-like protein 4, transcript variant X10
band 4.1-like protein 4, transcript variant X8
thyroid receptor-interacting protein 11-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
thyroid receptor-interacting protein 11-like, transcript variant X1
thyroid receptor-interacting protein 11-like isoform X1
thyroid receptor-interacting protein 11-like, transcript variant X3
thyroid receptor-interacting protein 11-like, transcript variant X2
thyroid receptor-interacting protein 11-like isoform X2
thyroid receptor-interacting protein 11-like isoform X3
homeodomain-interacting protein kinase 2, transcript variant X2
homeodomain-interacting protein kinase 2, transcript variant X5
homeodomain-interacting protein kinase 2, transcript variant X1
homeodomain-interacting protein kinase 2, transcript variant X4
homeodomain-interacting protein kinase 2, transcript variant X6
homeodomain-interacting protein kinase 2, transcript variant X9
homeodomain-interacting protein kinase 2, transcript variant X8
homeodomain-interacting protein kinase 2, transcript variant X14
homeodomain-interacting protein kinase 2, transcript variant X7
homeodomain-interacting protein kinase 2, transcript variant X12
homeodomain-interacting protein kinase 2, transcript variant X13
homeodomain-interacting protein kinase 2, transcript variant X11
homeodomain-interacting protein kinase 2, transcript variant X10
homeodomain-interacting protein kinase 2, transcript variant X3
homeodomain-interacting protein kinase 2 isoform X2
homeodomain-interacting protein kinase 2 isoform X5
homeodomain-interacting protein kinase 2 isoform X4
homeodomain-interacting protein kinase 2 isoform X10
homeodomain-interacting protein kinase 2 isoform X3
homeodomain-interacting protein kinase 2 isoform X8
homeodomain-interacting protein kinase 2 isoform X9
homeodomain-interacting protein kinase 2 isoform X7
homeodomain-interacting protein kinase 2 isoform X6
homeodomain-interacting protein kinase 2 isoform X1
homeodomain-interacting protein kinase 2, transcript variant X15
homeodomain-interacting protein kinase 2 isoform X11
homeodomain-interacting protein kinase 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
homeodomain-interacting protein kinase 2, transcript variant X16
probable GPI-anchored adhesin-like protein PGA55
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
lysosome-associated membrane glycoprotein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC122635292, transcript variant X3
uncharacterized LOC122635292, transcript variant X2
uncharacterized LOC122635292, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
histone H3.v1-like, transcript variant X2
histone H3.v1-like, transcript variant X4
histone H3.v1-like, transcript variant X5
histone H3.v1-like, transcript variant X3
histone H3.v1-like, transcript variant X1
uncharacterized LOC122635224, transcript variant X1
uncharacterized LOC122635224, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122635220, transcript variant X8
uncharacterized LOC122635220, transcript variant X9
uncharacterized LOC122635220, transcript variant X7
uncharacterized LOC122635220, transcript variant X6
uncharacterized LOC122635220, transcript variant X11
uncharacterized LOC122635220, transcript variant X12
uncharacterized LOC122635220, transcript variant X13
uncharacterized LOC122635220, transcript variant X10
uncharacterized LOC122635220, transcript variant X4
uncharacterized LOC122635220, transcript variant X15
uncharacterized LOC122635220, transcript variant X14
uncharacterized LOC122635220, transcript variant X3
uncharacterized LOC122635220, transcript variant X2
uncharacterized LOC122635220, transcript variant X5
uncharacterized LOC122635220, transcript variant X1
uncharacterized LOC122635218, transcript variant X4
uncharacterized LOC122635218, transcript variant X2
uncharacterized LOC122635218, transcript variant X1
uncharacterized LOC122635218, transcript variant X3
uncharacterized LOC122635218, transcript variant X5
uncharacterized LOC122635218, transcript variant X6
uncharacterized protein LOC122635218 isoform X1
uncharacterized protein LOC122635218 isoform X2
uncharacterized LOC122635219, transcript variant X1
uncharacterized LOC122635219, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
CWF19-like protein 2, transcript variant X2
CWF19-like protein 2, transcript variant X1
protein arginine methyltransferase NDUFAF7, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X3
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X5
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X7
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X6
mitogen-activated protein kinase kinase kinase kinase 5, transcript variant X8
mitogen-activated protein kinase kinase kinase kinase 5 isoform X2
mitogen-activated protein kinase kinase kinase kinase 5 isoform X5
mitogen-activated protein kinase kinase kinase kinase 5 isoform X1
mitogen-activated protein kinase kinase kinase kinase 5 isoform X3
mitogen-activated protein kinase kinase kinase kinase 5 isoform X4
mitogen-activated protein kinase kinase kinase kinase 5 isoform X7
mitogen-activated protein kinase kinase kinase kinase 5 isoform X6
mitogen-activated protein kinase kinase kinase kinase 3 isoform X8
uncharacterized LOC122635181, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122635181, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC122635181, transcript variant X4
uncharacterized LOC122635181, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122635181 isoform X3
uncharacterized protein LOC122635181 isoform X1
uncharacterized protein LOC122635181 isoform X2
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, transcript variant X1
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X1
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X3
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, transcript variant X2
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X2
uncharacterized LOC122635189, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122635189, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC122635189 isoform X1
uncharacterized protein LOC122635189 isoform X2
odorant receptor 4-like, transcript variant X1
odorant receptor 4-like, transcript variant X2
uncharacterized protein LOC122635187 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
odorant receptor 85c-like, transcript variant X2
odorant receptor 85c-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
odorant receptor 85c-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC122635186 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
brain tumor protein, transcript variant X7
brain tumor protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
brain tumor protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
brain tumor protein, transcript variant X6
brain tumor protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
brain tumor protein, transcript variant X5
brain tumor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
splicing factor, suppressor of white-apricot homolog, transcript variant X2
splicing factor, suppressor of white-apricot homolog, transcript variant X3
splicing factor, suppressor of white-apricot homolog, transcript variant X1
splicing factor, suppressor of white-apricot homolog, transcript variant X4
splicing factor, suppressor of white-apricot homolog, transcript variant X5
splicing factor, suppressor of white-apricot homolog isoform X2
splicing factor, suppressor of white-apricot homolog isoform X3
splicing factor, suppressor of white-apricot homolog isoform X1
splicing factor, suppressor of white-apricot homolog isoform X4
histone-lysine N-methyltransferase E(z), transcript variant X2
histone-lysine N-methyltransferase E(z), transcript variant X1
histone-lysine N-methyltransferase E(z), transcript variant X3
histone-lysine N-methyltransferase E(z) isoform X1
histone-lysine N-methyltransferase E(z) isoform X2
histone-lysine N-methyltransferase E(z) isoform X3
chitooligosaccharidolytic beta-N-acetylglucosaminidase
mediator of RNA polymerase II transcription subunit 10
condensin complex subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
condensin complex subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
condensin complex subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC122635240, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122635240, transcript variant X2
uncharacterized protein LOC122635240 isoform X2
uncharacterized protein LOC122635240 isoform X1
autophagy-related protein 101, transcript variant X1
autophagy-related protein 101, transcript variant X2
prolactin-releasing peptide receptor-like, transcript variant X1
prolactin-releasing peptide receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
prolactin-releasing peptide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
prolactin-releasing peptide receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prolactin-releasing peptide receptor-like
HMG box transcription factor BBX, transcript variant X2
HMG box transcription factor BBX isoform X2
HMG box transcription factor BBX, transcript variant X3
HMG box transcription factor BBX, transcript variant X5
HMG box transcription factor BBX isoform X3
HMG box transcription factor BBX, transcript variant X4
HMG box transcription factor BBX isoform X4
HMG box transcription factor BBX, transcript variant X1
HMG box transcription factor BBX isoform X1
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X4
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X2
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X1
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X6
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X3
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X4
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X2
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X1
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X3
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X6
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
arfGAP with SH3 domain, ANK repeat and PH domain-containing protein isoform X5
amyloid-beta-like protein, transcript variant X3
amyloid-beta-like protein, transcript variant X5
amyloid-beta-like protein, transcript variant X6
amyloid-beta-like protein, transcript variant X1
amyloid-beta-like protein, transcript variant X4
amyloid-beta-like protein, transcript variant X2
amyloid-beta-like protein, transcript variant X7
persulfide dioxygenase ETHE1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
40S ribosomal protein S19-like, transcript variant X1
40S ribosomal protein S19-like, transcript variant X2
uncharacterized LOC122635176, transcript variant X1
uncharacterized LOC122635176, transcript variant X3
uncharacterized LOC122635176, transcript variant X2
E3 ubiquitin-protein ligase Su(dx), transcript variant X5
E3 ubiquitin-protein ligase Su(dx), transcript variant X1
E3 ubiquitin-protein ligase Su(dx), transcript variant X2
E3 ubiquitin-protein ligase Su(dx), transcript variant X7
E3 ubiquitin-protein ligase Su(dx), transcript variant X6
E3 ubiquitin-protein ligase Su(dx), transcript variant X3
E3 ubiquitin-protein ligase Su(dx), transcript variant X4
uncharacterized LOC122635179, transcript variant X2
uncharacterized LOC122635179, transcript variant X1
uncharacterized protein LOC122635179 isoform X1
uncharacterized protein LOC122635179 isoform X2
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
serine/threonine-protein phosphatase 1 regulatory subunit 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
dihydropyrimidine dehydrogenase [NADP(+)], transcript variant X1
dihydropyrimidine dehydrogenase [NADP(+)], transcript variant X2
dihydropyrimidine dehydrogenase [NADP(+)] isoform X1
dihydropyrimidine dehydrogenase [NADP(+)] isoform X2
uncharacterized LOC122635069, transcript variant X2
uncharacterized LOC122635069, transcript variant X1
uncharacterized protein LOC122635069 isoform X2
uncharacterized protein LOC122635069 isoform X1
28S ribosomal protein S18b, mitochondrial
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1
trafficking protein particle complex subunit 3
lysM and putative peptidoglycan-binding domain-containing protein 2
protein catecholamines up, transcript variant X1
protein catecholamines up, transcript variant X2
DNA repair protein RAD52 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA repair protein RAD52 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
DNA repair protein RAD52 homolog isoform X2
DNA repair protein RAD52 homolog isoform X1
transmembrane protein 268, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane protein 268, transcript variant X2
transmembrane protein 268, transcript variant X3
uncharacterized protein LOC122635065 isoform X3
tetratricopeptide repeat protein 19 homolog, mitochondrial, transcript variant X3
tetratricopeptide repeat protein 19 homolog, mitochondrial, transcript variant X1
tetratricopeptide repeat protein 19 homolog, mitochondrial, transcript variant X2
tetratricopeptide repeat protein 19 homolog, mitochondrial, transcript variant X4
tetratricopeptide repeat protein 19 homolog, mitochondrial isoform X4
tetratricopeptide repeat protein 19 homolog, mitochondrial isoform X1
tetratricopeptide repeat protein 19 homolog, mitochondrial isoform X3
tetratricopeptide repeat protein 19 homolog, mitochondrial isoform X2
SAP30-binding protein, transcript variant X2
SAP30-binding protein, transcript variant X1
SAP30-binding protein, transcript variant X4
SAP30-binding protein, transcript variant X3
ADP-ribosylation factor-binding protein GGA3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
pyruvate dehydrogenase E1 component subunit beta, mitochondrial, transcript variant X2
pyruvate dehydrogenase E1 component subunit beta, mitochondrial, transcript variant X1
pyruvate dehydrogenase E1 component subunit beta, mitochondrial isoform X2
pyruvate dehydrogenase E1 component subunit beta, mitochondrial isoform X1
acidic fibroblast growth factor intracellular-binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
acidic fibroblast growth factor intracellular-binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
acidic fibroblast growth factor intracellular-binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
acidic fibroblast growth factor intracellular-binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
acidic fibroblast growth factor intracellular-binding protein isoform X4
acidic fibroblast growth factor intracellular-binding protein isoform X2
acidic fibroblast growth factor intracellular-binding protein isoform X3
acidic fibroblast growth factor intracellular-binding protein isoform X1
growth/differentiation factor 8, transcript variant X2
growth/differentiation factor 8, transcript variant X1
growth/differentiation factor 8 isoform X2
growth/differentiation factor 8 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
microphthalmia-associated transcription factor, transcript variant X5
microphthalmia-associated transcription factor, transcript variant X4
microphthalmia-associated transcription factor isoform X4
microphthalmia-associated transcription factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microphthalmia-associated transcription factor, transcript variant X1
microphthalmia-associated transcription factor, transcript variant X2
microphthalmia-associated transcription factor isoform X1
microphthalmia-associated transcription factor isoform X2
microphthalmia-associated transcription factor isoform X3
uncharacterized LOC122635023, transcript variant X1
uncharacterized LOC122635023, transcript variant X2
uncharacterized LOC122635021, transcript variant X1
uncharacterized LOC122635021, transcript variant X2
thrombospondin type-1 domain-containing protein 4-like, transcript variant X3
thrombospondin type-1 domain-containing protein 4-like, transcript variant X4
thrombospondin type-1 domain-containing protein 4-like, transcript variant X2
thrombospondin type-1 domain-containing protein 4-like, transcript variant X1
thrombospondin type-1 domain-containing protein 4-like, transcript variant X6
thrombospondin type-1 domain-containing protein 4-like, transcript variant X5
thrombospondin type-1 domain-containing protein 4-like isoform X1
thrombospondin type-1 domain-containing protein 4-like isoform X2
thrombospondin type-1 domain-containing protein 4-like isoform X3
thrombospondin type-1 domain-containing protein 4-like, transcript variant X7
thrombospondin type-1 domain-containing protein 4-like, transcript variant X8
thrombospondin type-1 domain-containing protein 4-like isoform X4
thrombospondin type-1 domain-containing protein 4-like isoform X5
armadillo repeat-containing protein 6 homolog, transcript variant X2
armadillo repeat-containing protein 6 homolog, transcript variant X1
armadillo repeat-containing protein 6 homolog
GDP-fucose protein O-fucosyltransferase 1
sorting nexin-24-like, transcript variant X1
sorting nexin-24-like, transcript variant X2
semaphorin-1A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
semaphorin-1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
alpha/beta hydrolase domain-containing protein 17B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
homer protein homolog 2, transcript variant X2
homer protein homolog 2, transcript variant X1
homer protein homolog 2, transcript variant X3
methylosome subunit pICln, transcript variant X2
methylosome subunit pICln, transcript variant X3
methylosome subunit pICln, transcript variant X1
D-aminoacyl-tRNA deacylase 1, transcript variant X1
D-aminoacyl-tRNA deacylase 1, transcript variant X2
D-aminoacyl-tRNA deacylase 1, transcript variant X4
D-aminoacyl-tRNA deacylase 1, transcript variant X3
GRIP and coiled-coil domain-containing protein 1
protein capicua homolog, transcript variant X5
protein capicua homolog, transcript variant X1
protein capicua homolog, transcript variant X7
protein capicua homolog, transcript variant X2
protein capicua homolog, transcript variant X10
protein capicua homolog, transcript variant X8
protein capicua homolog, transcript variant X12
protein capicua homolog, transcript variant X9
protein capicua homolog, transcript variant X11
protein capicua homolog, transcript variant X6
protein capicua homolog, transcript variant X3
protein capicua homolog, transcript variant X4
putative transcription factor capicua isoform X6
histone-lysine N-methyltransferase trithorax, transcript variant X3
histone-lysine N-methyltransferase trithorax, transcript variant X1
histone-lysine N-methyltransferase trithorax, transcript variant X2
histone-lysine N-methyltransferase trithorax
ALK tyrosine kinase receptor, transcript variant X5
ALK tyrosine kinase receptor, transcript variant X1
ALK tyrosine kinase receptor, transcript variant X2
ALK tyrosine kinase receptor, transcript variant X3
ALK tyrosine kinase receptor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122635030, transcript variant X2
uncharacterized LOC122635030, transcript variant X1
uncharacterized protein LOC122635030 isoform X1
uncharacterized protein LOC122635030 isoform X2
patched domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122635028, transcript variant X1
uncharacterized protein LOC122635028 isoform X1
uncharacterized LOC122635028, transcript variant X2
uncharacterized LOC122635028, transcript variant X3
uncharacterized LOC122635028, transcript variant X4
uncharacterized protein LOC122635028 isoform X2
uncharacterized LOC122635031, transcript variant X2
uncharacterized LOC122635031, transcript variant X1
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X2
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X1
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X2
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X1